IPO

Trident Lifeline Limited IPO

BSE SME

Listed On: Oct 10, 2022 at ₹ 105.00

₹ 242400 /2400 Shares
*Min Investment

Check Allotment

26 Sep, 2022

Open Date

29 Sep, 2022

Close Date

04 Oct, 2022

Allotment Date

10 Oct, 2022

Listing Date
Trident Lifeline IPO Issue Details
  • Issue Price ₹101 per equity share
  • Face Value ₹10 Per Equity Share 
  • Issue Price 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr)

    #Fresh Issue: 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr)
  • Listing at BSE SME
  • List Price 105.00
  • Listing Date 2022-10-10
  • Lead Manager Beeline Capital Advisors Pvt Ltd
  • Registrar Link Intime India Private Ltd
Trident Lifeline IPO Details
  • Retail Portion N/A
Trident Lifeline IPO Documents
Trident Lifeline IPO Details


Trident Lifeline Limited IPO is an SME IPO, priced at ₹101 per equity share. The equity shares have a face value of ₹10 Per Equity Share  each and will be listed on the BSE SME platform.

The IPO bidding window is open from Sep 26, 2022 to Sep 29, 2022. The allotment is expected to be finalized on Oct 4, 2022, and the tentative listing date is Oct 10, 2022.


The registrar of the IPO is Link Intime India Private Ltd, and

Read More
Trident Lifeline IPO Subscription Analysis And Details
Retail
0.98x
Total
1.34x
As onQIB / NIIRetailTotal
Shares Offered / Reserved1,662,0001,662,0003,324,000
Day 1 26-09-22 06:00 PM
0.07 x0.06 x0.06 x
Day 2 27-09-22 06:00 PM
0.43 x0.33 x0.38 x
Day 3 28-09-22 06:00 PM
0.63 x0.52 x0.58 x
Day 4 29-09-22 06:00 PM
1/40 x0.98 x1.34 x
Trident Lifeline Valuations
Earnings Per Share (EPS) ₹N/A/-
P/E Ratio N/A
RoNW N/A%
Net Asset Value (NAV) - Post Issue ₹N/A/-
Trident Lifeline Company Financials
In Lakhs
In Lakh
30-Mar-2231-Mar-2131-Mar-20
Assets1385.981144.41638.92
Revenue2237.14978.13500.71
Profit After Tax227.3263.23-79.63
About Trident Lifeline Company

Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.

Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan licence.

Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs).

Read More
Trident Lifeline - Promoter(s)

Mr. Hardik Jigishkumar Desai

Mr. Mayurkumar Mansukhbhai Gajera

Mrs. Rupaben C Jariwala

Mrs. Rinkal Mayurbhai Gajera

Mr. Tarang Nathabhai Gajera

Mr. Mohak Nathabhai Gajera

Pre Issue Share Holding : 100%

Post Issue Share Holding : 69.57%

Trident Lifeline IPO - Issue Objectives
1

To Meet Working Capital Requirements

2

Product registration in the international markets

3

General Corporate Purpose

4

To meet Public Issue Expenses